JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Zundert, B.
Right arrow Articles by Aguayo, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Zundert, B.
Right arrow Articles by Aguayo, L. G.

Vol. 295, Issue 1, 423-429, October 2000

Effects of Chronic Ethanol Treatment on gamma -Aminobutyric AcidA and Glycine Receptors in Mouse Glycinergic Spinal Neurons1

Brigitte van Zundert, Felipe A. Albarran and Luis G. Aguayo

Laboratory of Neurophysiology, Department of Physiology, University of Concepción, Concepción, Chile

Five-day-old cultures of mouse glycinergic spinal interneurons were chronically treated with 100 mM ethanol and the glycine and gamma -aminobutyric acid (GABA)A receptors were assayed using whole-cell recordings and fluorescence-imaging techniques. Control neurons displayed a glycine50 of 19 ± 0.6 µM and a Hill coefficient of 3.1 ± 0.3. Chronic ethanol treatment did not significantly change these parameters. The maximal responses were 310 ± 80 pA/pF in control and 440 ± 19 pA/pF in treated cells, and the fluorescence intensity associated to a monoclonal glycine receptor antibody was unchanged. Strychnine inhibited the glycine current with smaller potency (29%) in treated neurons, thus the IC50 increased from 14 ± 2 nM in control to 18 ± 6 nM in treated neurons. Zn2+ (10 µM) potentiated the glycine current by 43 ± 33% in control, but only by 18 ± 13% in treated neurons. Interestingly, no change on the inhibition produced by a high concentration of Zn2+ was found in treated neurons. The inhibitory effect of picrotoxin on the glycine receptor, associated to a homomeric receptor, was eliminated with chronic ethanol, suggesting a faster switch to beta -subunit-containing receptors. Unlike glycine receptors, the sensitivity of GABAA receptors to GABA, pentobarbital, diazepam, and Zn2+, as well as the fluorescence intensity associated to a high-affinity benzodiazepine analog was unchanged by chronic ethanol. In conclusion, we found that glycine receptors in spinal interneurons were altered by chronic ethanol treatment and this may reflect the expression of different subunits in control and treated neurons. GABAA receptors were resistant to the treatment.


1 This research was partly funded by Fondecyt Grants 1950917 and 1980106.


0022-3565/00/2951-0423$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Physiol.Home page
C. Dubois, H. Houchi, M. Naassila, M. Daoust, and O. Pierrefiche
Blunted response to low oxygen of rat respiratory network after perinatal ethanol exposure: involvement of inhibitory control
J. Physiol., March 1, 2008; 586(5): 1413 - 1427.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Sanna, M. C. Mostallino, F. Busonero, G. Talani, S. Tranquilli, M. Mameli, S. Spiga, P. Follesa, and G. Biggio
Changes in GABAA Receptor Gene Expression Associated with Selective Alterations in Receptor Function and Pharmacology after Ethanol Withdrawal
J. Neurosci., December 17, 2003; 23(37): 11711 - 11724.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.